Exosomal NAMPT from Engineered Mesenchymal Stem Cells Mitigates Aortic Stenosis via Metabolic and Anti-Inflammatory Pathways

Dipan Kumar Kundu, Matthew Kiedrowski, James Gadd, Min Gao, Madeline Evan, Yang Wang, Liya Yin, Vahagn Ohanyan, William M. Chilian, Feng Dong · 2025

Read Exosomal NAMPT from Engineered Mesenchymal Stem Cells Mitigates Aortic Stenosis via Metabolic and Anti-Inflammatory Pathways by Dipan Kumar Kundu, Matthew Kiedrowski, James Gadd, Min Gao, Madeline Evan, Yang Wang, Liya Yin, Vahagn Ohanyan, William M. Chilian, Feng Dong (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785966.txt.

Description

Dipan Kumar Kundu and nine colleagues test whether engineered stem cell exosomes can slow aortic stenosis, a stiffening of the heart's aortic valve, in a 2025 study. They loaded mesenchymal stem cell exosomes with extra NAMPT, a protein that drops in diseased hearts. Mice bred to develop the condition got weekly injections of the enriched exosomes, plain exosomes, or a control solution.

The enriched exosomes lowered valve flow speed, thinning, and calcium deposits while improving heart pumping measures. They also normalized one small RNA, miR-146a-3p, that drives a harmful cell change in valve tissue. Blocking that RNA in the lab curbed the same change. The authors propose both the exosomes and the RNA as therapy leads.

Catalog record

CREATORDipan Kumar Kundu, Matthew Kiedrowski, James Gadd, Min Gao, Madeline Evan, Yang Wang, Liya Yin, Vahagn Ohanyan, William M. Chilian, Feng Dong
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12785966

Browse the full library · About the Tower of Babel